Patents by Inventor Andrea Tortori

Andrea Tortori has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210301330
    Abstract: The present invention concerns a method for detecting and/or quantifying a target nucleotide sequence (3) in a sample comprising the steps of: providing the target nucleotide sequence (3) as a single strand; hybridizing said target nucleotide sequence (3) with a first probe (1) of single strand nucleic acid and with a second probe (2) of single strand nucleic acid, the first probe (1) being immobilised at one end to a solid support (4) and comprising, at the opposite end, a sequence complementary to a first portion (5) of the target nucleotide sequence (3), the second probe (2) being marked at one end and comprising, at the opposite end, a sequence complementary to a second portion (6) of target nucleotide sequence (3), wherein the first portion (5) and the second portion (6) of target nucleotide sequence have 2 to 10 nucleotides in common, so as to form a first probe-target nucleotide sequence-second probe complex; and detect the complex. The present invention also concerns a kit for use in the method.
    Type: Application
    Filed: August 9, 2019
    Publication date: September 30, 2021
    Inventors: Andrea Tortori, Nicolo Rossi
  • Patent number: 10752900
    Abstract: The present invention regards oligonucleotides for modulating the expression of a gene, in particular for modulating a gene responsible for a pathology of genetic, tumoural or viral origin. Moreover, the present invention relates to the use of said oligonucleotides, possibly chemically modified, for the treatment and/or the diagnosis of said diseases.
    Type: Grant
    Filed: June 15, 2018
    Date of Patent: August 25, 2020
    Assignee: BIOGENERA S.P.A.
    Inventors: Roberto Tonelli, Leonardo Venturelli, Andrea Tortori, Luca Montemurro
  • Publication number: 20180282731
    Abstract: The present invention regards oligonucleotides for modulating the expression of a gene, in particular for modulating a gene responsible for a pathology of genetic, tumoural or viral origin. Moreover, the present invention relates to the use of said oligonucleotides, possibly chemically modified, for the treatment and/or the diagnosis of said diseases.
    Type: Application
    Filed: June 15, 2018
    Publication date: October 4, 2018
    Applicant: BIOGENERA S.P.A.
    Inventors: Roberto Tonelli, Leonardo Venturelli, Andrea Tortori, Luca Montemurro
  • Patent number: 10023867
    Abstract: The present invention regards oligonucleotides for modulating the expression of a gene, in particular for modulating a gene responsible for a pathology of genetic, tumoral or viral origin. Moreover, the present invention relates to the use of said oligonucleotides, possibly chemically modified, for the treatment and/or the diagnosis of said diseases.
    Type: Grant
    Filed: February 21, 2013
    Date of Patent: July 17, 2018
    Assignee: BIOGENERA S.P.A.
    Inventors: Roberto Tonelli, Leonardo Venturelli, Andrea Tortori, Luca Montemurro
  • Publication number: 20160040166
    Abstract: The present invention regards oligonucleotides for modulating the expression of a gene, in particular for modulating a gene responsible for a pathology of genetic, tumoural or viral origin. Moreover, the present invention relates to the use of said oligonucleotides, possibly chemically modified, for the treatment and/or the diagnosis of said diseases.
    Type: Application
    Filed: February 21, 2013
    Publication date: February 11, 2016
    Inventors: Roberto Tonelli, Leonardo Venturelli, Andrea Tortori, Luca Montemurro